Use of Blood Products

Patients in the pediatric intensive care unit (PICU) frequently receive transfusions of blood products. While these therapies are often beneficial, they can be associated with significant, yet often overlooked, risks. Clinical guidelines for blood product transfusions must be well defined in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cholette, Jill M., Lerner, Norma B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178832/
http://dx.doi.org/10.1007/978-0-85729-923-9_20
_version_ 1783525546680909824
author Cholette, Jill M.
Lerner, Norma B.
author_facet Cholette, Jill M.
Lerner, Norma B.
author_sort Cholette, Jill M.
collection PubMed
description Patients in the pediatric intensive care unit (PICU) frequently receive transfusions of blood products. While these therapies are often beneficial, they can be associated with significant, yet often overlooked, risks. Clinical guidelines for blood product transfusions must be well defined in order to prevent misuse of this limited resource. It is important for the intensivist to have a thorough understanding of the indications for specific blood products, and the transfusion needs of particular patient populations.
format Online
Article
Text
id pubmed-7178832
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-71788322020-04-23 Use of Blood Products Cholette, Jill M. Lerner, Norma B. Pediatric Critical Care Study Guide Article Patients in the pediatric intensive care unit (PICU) frequently receive transfusions of blood products. While these therapies are often beneficial, they can be associated with significant, yet often overlooked, risks. Clinical guidelines for blood product transfusions must be well defined in order to prevent misuse of this limited resource. It is important for the intensivist to have a thorough understanding of the indications for specific blood products, and the transfusion needs of particular patient populations. 2011-12-16 /pmc/articles/PMC7178832/ http://dx.doi.org/10.1007/978-0-85729-923-9_20 Text en © Springer-Verlag London Limited 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Cholette, Jill M.
Lerner, Norma B.
Use of Blood Products
title Use of Blood Products
title_full Use of Blood Products
title_fullStr Use of Blood Products
title_full_unstemmed Use of Blood Products
title_short Use of Blood Products
title_sort use of blood products
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178832/
http://dx.doi.org/10.1007/978-0-85729-923-9_20
work_keys_str_mv AT cholettejillm useofbloodproducts
AT lernernormab useofbloodproducts

Ejemplares similares